Skip to main content

Advertisement

Log in

Association of depressive symptoms with circadian blood pressure alterations in Parkinson’s disease

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

To assess whether among patients with Parkinson’s disease (PD) depression, a common non-motor symptom associated with reduced survival, is associated with cardiovascular dysautonomia. We enrolled 125 subjects with PD consecutively admitted to a geriatric day hospital. All participants underwent comprehensive evaluation, fasting blood sampling, and 24-h ambulatory blood pressure monitoring. The percent reduction in nocturnal blood pressure (dipping) was calculated. Depressive symptoms were assessed through the 15-item Geriatric Depression Scale (GDS); a score ≥5 identified moderate to severe symptoms. Among participants (mean age 72.7 ± 7.8 years, 32 % women) 61 subjects (49 %) presented with a GDS score ≥ 5. When compared with other participants, subjects with a GDS score ≥ 5 had reduced adjusted levels of percent systolic (−2.6 ± 2.7 vs. 4.7 ± 2.5; p = 0.003), diastolic (0.6 ± 2.8 vs. 7.4 ± 2.6; p = 0.007), and mean blood pressure dipping (−0.7 ± 2.6 vs. 6.8 ± 2.5; p = 0.002). In separate logistic regression models, depressive symptoms were associated with reduced systolic (OR 0.94; 95 % CI 0.89; 0.98), diastolic (OR 0.94; 95 % CI 0.90; 0.99), and mean blood pressure dipping (OR 0.93; 95 % CI 0.89; 0.98), after adjusting for potential confounders. Depressive symptoms are prevalent, and independently associated with cardiovascular dysautonomia among patients with Parkinson’s disease. This might explain the remarkable incidence of sudden death, as well as the association of depressive symptoms with reduced survival reported in these patients. The finding of depressive symptoms in subjects with Parkinson’s disease should therefore prompt assessment of cardiovascular autonomic function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Velseboer DC, Broeders M, Post B et al (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80(7):627–633

    Article  PubMed  Google Scholar 

  2. Barone P, Antonini A, Colosimo C et al (2009) PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. doi:10.1002/mds.22643

    Article  PubMed  Google Scholar 

  3. Laudisio A, Vetrano DL, Meloni E et al (2014) Dopaminergic agents and nutritional status in Parkinson’s disease. Mov Disord 29(12):1543–1547. doi:10.1002/mds.25991

    Article  CAS  PubMed  Google Scholar 

  4. Jain S (2011) Multi-organ autonomic dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 17(2):77–83

    Article  PubMed Central  PubMed  Google Scholar 

  5. Dickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1–S5

    Article  PubMed  Google Scholar 

  6. Asahina M, Vychanrat E, Low DA et al (2013) Autonomic Dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurolg Neurosurg Psychiatry 84(6):674–680

    Article  Google Scholar 

  7. Stuebner E, Vichayanrat E, Low DA et al (2013) Twenty-four hour non invasive ambulatory blood pressure monitoring in Parkinson’s disease. Front Neurol 4:49. doi:10.3389/fneur.2013.00049

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ravina B, Camicioli R, Como PG et al (2007) The impact of depressive symptoms in early Parkinson disease. Neurology 69(4):342–347

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Hughes TA, Ross HF, Mindham RH et al (2004) Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand 110(2):118–123

    Article  CAS  PubMed  Google Scholar 

  10. Sagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715

    Article  PubMed  Google Scholar 

  11. Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP 55:181–184

    CAS  Google Scholar 

  12. Almeida OP, Almeida SA (1999) Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 14(10):858–865

    Article  CAS  PubMed  Google Scholar 

  13. Friedman B, Heisel MJ, Delavan RL (2005) Psychometric properties of the 15-item geriatric depression scale in functionally impaired, cognitively intact, community-dwelling elderly primary care patients. J Am Geriatr Soc 53(9):1570–1576

    Article  PubMed  Google Scholar 

  14. Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653

    Article  PubMed  Google Scholar 

  15. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022

    Article  Google Scholar 

  16. Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792

    Article  CAS  PubMed  Google Scholar 

  17. Dissanayaka NN, Sellbach A, Silburn PA et al (2011) Factors associated with depression in Parkinson’s disease. J Affect Disord 132(1–2):82–88. doi:10.1016/j.jad.2011.01.021

    Article  PubMed  Google Scholar 

  18. Ravina B, Elm J, Camicioli R et al (2009) The course of depressive symptoms in early Parkinson’s disease. Mov Disord 24(9):1306–1311. doi:10.1002/mds.22572

    Article  PubMed Central  PubMed  Google Scholar 

  19. Pachana NA, Egan SJ, Laidlaw K et al (2013) Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s disease. Mov Disord 28(14):1930–1934. doi:10.1002/mds.25689

    Article  PubMed  Google Scholar 

  20. Remy P, Doder M, Lees A et al (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322

    Article  PubMed  Google Scholar 

  21. Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson’s disease. Parkinsonism Relat Disord 15(2):144–148. doi:10.1016/j.parkreldis.2008.04.038

    Article  PubMed Central  PubMed  Google Scholar 

  22. Menza M, Dobkin RD, Dicke A (2009) A controlled trial of antidepressants in patients with Parkinson’s disease. Neurology 72(10):886–892

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Rektorova I, Rektor I, Bares M et al (2013) Pramipexole and Pergolide in treatment of depression in Parkinson’s disease: a national multicentre prospective randomized study. Eur J Neurol 10(4):399–406

    Article  Google Scholar 

  24. Braak H, Ghebremedhin E, Rüb U et al (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134

    Article  PubMed  Google Scholar 

  25. Comi C, Magistrelli L, Oggioni GD et al (2014) Peripheral nervous system involvement in Parkinson’s disease: evidence and controversies. Parkinsonism Relat Disord 20(12):1329–1334. doi:10.1016/j.parkreldis.2014.10.010

    Article  CAS  PubMed  Google Scholar 

  26. Drago S, Bergerone S, Anselmino M et al (2007) Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol 115(1):46–51

    Article  PubMed  Google Scholar 

  27. Matsumoto H, Sengoku R, Saito Y et al (2014) Sudden death in Parkinson’s disease: a retrospective autopsy study. J Neurol Sci 343(1–2):149–152. doi:10.1016/j.jns.2014.05.060

    Article  PubMed  Google Scholar 

  28. Ishizaki F, Harada T, Yoshinaga H et al (1996) Prolonged QTc intervals in Parkinson’s disease–relation to sudden death and autonomic dysfunction. No To Shinkei 48(5):443–448

    CAS  PubMed  Google Scholar 

  29. Nakamoto T, Matsukawa K, Liang N et al (2011) Coactivation of renal sympathetic neurons and somatic motor neurons by chemical stimulation of the midbrain ventral tegmental area. J Appl Physiol 110(5):1342–1353. doi:10.1152/japplphysiol.01233.2010

    Article  PubMed  Google Scholar 

  30. Murata Y, Harada I, Ishizaki F et al (1997) Autonomic dysfunction in Parkinson’s disease and vascular parkinsonism. Acta Neurol Scand 96:359–365

    Article  CAS  PubMed  Google Scholar 

  31. Vriend C, Raijmakers P, Veltman DJ et al (2014) Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159–164. doi:10.1136/jnnp-2012-304811

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Davide L. Vetrano.

Ethics declarations

Conflicts of interest

None.

Ethical standard

The present non-interventional study has been carried out in agreement with the 1964 Declaration of Helsinki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vetrano, D.L., Pisciotta, M.S., Lo Monaco, M.R. et al. Association of depressive symptoms with circadian blood pressure alterations in Parkinson’s disease. J Neurol 262, 2564–2571 (2015). https://doi.org/10.1007/s00415-015-7887-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7887-0

Keywords

Navigation